Ulcerative colitis is an inflammatory disease of unknown origin, characterized clinically by recurrent attacks of bloody diarrhoea and pathologically by a diffuse inflammation of the wall of the large bowel. The changes spread proximally from the rectum, and are confined to (or most severe in) the colonic and rectal mucosa.I The disease was first mentioned by name in 1859 by Sir Samuel Wi ¶ks2 (though similar noncontagious forms of diarrhoea have been recorded for almost 2,000 years, dating back to a description in A.D. 117 by Soranus of Ephesus3). Nonetheless, the last decade has seen a considerable surge of interest in the disease.
Epidemiology
Ulcerative colitis is often alleged to be a disease of industrialized Western countries. Certainly it is most commonly found in Britain, where the incidence is roughly 5 per 100,000 of the population at risk, and the prevalence roughly 80 per 100,000. Roughly each patient has somewhat less than a fifty-fifty chance of experiencing symptoms from ulcerative colitis in a given year and this risk is unaffected by the patient's age, sex, duration of symptoms, or extent of diseased bowel. Nevertheless, some patients may even suffer from chronic continuous disease, though this seems to have become rarer recently. The severity of disease is influenced by several factors, of which three are the most important. The first is the duration of symptoms; the first attack is often the most severe and carries the greatest risk (though once this is over the duration of disease seems to have little effect on its severity, and "burnt-out" colitis is hardly a valid term). Secondly, the age of the patient; the very young and the very old are far more likely to suffer from severe attacks than those in intermediate age groups. Last and most important, is the extent of disease; since patients with extensive or total colitis are more likely to suffer from severe attacks of disease than those with proctitis or distal colitis. (In the Leeds series the risk of an attack being a severe one was increased five-fold by the presence of extensive disease.)
Incidentally, though the classification of severity put forward by S. C. Truelove and L. J. Witts" 15 years ago is often criticised, no superior classification has yet been put forward, and in practice it is extremely useful. On the other hand, the word "fulminating" has been the subject of several mutually incompatible definitions and should be dropped.
PROGNOSIS
The prognosis of any patient suffering from ulcerative colitis depends on a combination of three factors: age; the extent of bowel affected; and, if the disease is active, the severity of attack. The mortality is highest in patients over the age of 60, those who suffer from severe attacks, and those with extensive disease, involving all or nearly all of the colon and rectum. Combinations of these poor prognositc factors are particularly lethal. This knowledge has enabled us to propose a much more rational system of management and to define more precisely the respective roles of conservative and operative therapy. Equally important has been the realization that many of the complications of ulcerative colitis-local, like perforation, stricture, or perianal sepsis, and "systemic" such as uveitis, arthritis, or skin lesions-are also somewhat influenced by the extent and particularly the activity of the patient's colitis. Indeed, many of these complications disappear entirely after removal of the bowel.
Finally cancer of the large bowel is found almost exclusively in patients with extensive colitis, among whom the cancer risk varies according to their duration of symptoms. In the Leeds series the cumulative cancer risk in patients with extensive colitis was around 5% after 10 years and no less than 41.8% after 25 years. This has led to the suggestion that prophylactic surgery on the grounds of cancer prevention may be justifiable if the patient has extensive colitis and a ten-year history; but this is a major step for the patient, 
